HYPERION DEFI, INC. Notes Payable
HYPERION DEFI, INC. (HYPD) had Notes Payable of $8.44 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:NotesPayable · last filed 2026-08-13
- 2026-06-30: Notes Payable $8.44M.
- 2026-03-31: Notes Payable $8.47M.
- 2025-12-31: Notes Payable $7.80M.
- 2023-03-31: Notes Payable $10.93M.
| Period end | Notes Payable |
|---|---|
| 2026-06-30 | $8.44M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.47M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.80M 10-Q · filed 2026-08-13 |
| 2023-03-31 | $10.93M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $10.43M 10-Q · filed 2023-05-12 |
| 2022-06-30 | $7.73M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $8.06M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $7.50M 10-K · filed 2023-03-31 |
| 2021-09-30 | $7.28M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $7.95M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.09M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $463.35K 10-K · filed 2022-03-30 |
| 2020-09-30 | $570.28K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $729.25K 10-Q · filed 2020-08-14 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |